Diseases & Conditions Market Research Reports & Industry Analysis
Insomnia is a common condition in which one has trouble going to sleep or staying asleep. This condition can range from weak to strong, depending on how often it occurs and for how long. Insomnia can be ongoing or acute. Chronic insomnia means having symptoms at least 3 nights a week for more than a month. Acute insomnia lasts for less time. Some people who have insomnia will have trouble falling asleep. Other people may fall asleep easily but, then wake up.
Diseases & Conditions Industry Research & Market Reports
-
Intelligent Pumps
... at a CAGR of 6.1% over the analysis period 2023-2030. Centrifugal Pumps, one of the segments analyzed in the report, is expected to record a 6.6% CAGR and reach US$1.5 Billion by the end of ... Read More
-
Asthma Therapeutics
... at a CAGR of 2.3% over the analysis period 2023-2030. Anti-Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 2.5% CAGR and reach US$10.7 Billion by the end of ... Read More
-
Autoimmune Disease Diagnosis
... by 2030, growing at a CAGR of 5.3% over the period 2023-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record 5.6% CAGR and reach US$4.1 Billion by ... Read More
-
Electric Bicycle Motors
... by 2030, growing at a CAGR of 5.1% over the analysis period 2023-2030. Pedal Assisted Bicycle Motors, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$6.1 ... Read More
-
Crohn`s Disease (CD) Therapy
... reach US$17.7 Billion by 2030, growing at a CAGR of 4.8% over the analysis period 2023-2030. Anti-TNF Biologics, one of the segments analyzed in the report, is expected to record a 5.8% CAGR and reach ... Read More
-
Multiple Sclerosis - Pipeline Insight, 2024
... including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global ... Read More
-
Attitude and Heading Reference Systems
... is expected to reach US$874.3 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2023-2030. Conventional AHRS, one of the segments analyzed in the report, is expected to record a 3.8% ... Read More
-
Automated Passenger Information Systems
... reach US$14.2 Billion by 2030, growing at a CAGR of 6.9% over the period 2023-2030. Passenger Information Systems, one of the segments analyzed in the report, is expected to record 7.3% CAGR and reach US$8.8 ... Read More
-
Automotive Paints
... at a CAGR of 2.7% over the analysis period 2023-2030. Clearcoat, one of the segments analyzed in the report, is expected to record a 2.2% CAGR and reach US$1.9 Billion by the end of the ... Read More
-
Library Furniture
... at a CAGR of 8.7% over the analysis period 2023-2030. Tables, one of the segments analyzed in the report, is expected to record a 8.9% CAGR and reach US$3.9 Billion by the end of the ... Read More
-
De-oiled Lecithin
... at a CAGR of 6.6% over the analysis period 2023-2030. Food Application, one of the segments analyzed in the report, is expected to record a 6.7% CAGR and reach US$194.9 Million by the end of ... Read More
-
Injection Pens
... at a CAGR of 5.9% over the analysis period 2023-2030. Disposable Injection Pens, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$50.0 Billion by the end ... Read More
-
Electrical Stimulation Devices
... by 2030, growing at a CAGR of 8.0% over the analysis period 2023-2030. Pain Management Application, one of the segments analyzed in the report, is expected to record a 8.3% CAGR and reach US$5.4 Billion ... Read More
-
Electroceramics
... of 5.4% over the analysis period 2023-2030. Dielectric ceramics, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$7.7 Billion by the end of the analysis period. ... Read More
-
Proteases
... of 5.5% over the analysis period 2023-2030. Microbes- sourced Proteases, one of the segments analyzed in the report, is expected to record a 5.9% CAGR and reach US$3.6 Billion by the end of the analysis ... Read More
-
Global Alpha Glucosidase Inhibitors Market 2024-2028
... forecast period. The report on the alpha glucosidase inhibitors market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Epidemiology Forecast - 2034
... Syndrome in the US were ~50,090. In 2023, the total diagnosed prevalent cases of Early Myoclonic Encephalopathy in Japan were around 20, where as the diagnosed prevalent cases of Epileptic Encephalopathy with continuous spike-and-wave during ... Read More
-
Developmental and Epileptic Encephalopathies (DEE) - Market Insight, Epidemiology And Market Forecast - 2034
... which is expected to grow at a CAGR of ~40% during the forecast period (2020-2034). Among EU4 and the UK, Germany will capture the maximum revenue share, followed by Italy in 2034. In the 7MM, ... Read More
-
Non-Muscle Invasive Bladder Cancer (NMIBC) Market Insight, Epidemiology And Market Forecast - 2034
... these cases is expected to increase by 2034. In 2023, the market size of presbyopia was highest in the US among the 7MM, accounting for approximately USD 8,039 million which is further expected to increase ... Read More
-
Global IBD (Ulcerative Colitis and Crohn's Disease) Treatment Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
... Treatment market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period. The global pharmaceutical market is ... Read More
-
Chronic Obstructive Pulmonary Disease (COPD) Market Global Forecast Report by Types (Chronic Bronchitis, Emphysema) Treatment Types (Drugs, Oxygen Therapy, Surgery, Others) Distribution Channels (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) Countries and Company Analysis, 2024-2032
... Food Market Analysis Global Diabetic Food Market was US$ 13.80 Billion in 2023 and will grow US$ 23.33 Billion by 2032, with a CAGR of 6.01% from 2024 to 2032. The rising incidence of diabetes, ... Read More
-
Global Rapid Acting Insulin Market Report Forecast by Product (Lispro Insulin, Aspart Insulin, Glulisine Insulin) Indication (Type 1 Diabetes, Type 2 Diabetes) Distribution Channel (Hospital Pharmacies, Drug Stores and Retail Pharmacies, Online Stores), Countries and Company Analysis (2024-2032)
... Company Analysis (2024-2032) Global Cotton Market Size The global cotton market is expected to reach US$ 41.83 billion in 2023 to US$ 53.64 billion by 2032, with a CAGR of 2.80% from 2024 to 2032. ... Read More
-
Cancer Monoclonal Antibodies - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Others), End-User (Hospitals, Research Institutions & Laboratories, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the rising ... Read More
-
Short-Acting Insulin - Market Insights, Competitive Landscape, and Market Forecast - 2030
... Store & Retail Pharmacies, and Online Providers), and Geography (North America, Europe, Asia-Pacific, and rest of the World) is expected to grow at a steady CAGR forecast till 2030 owing to the growing prevalence of ... Read More
-
Global Gastric Cancer Market (2024 Edition): Analysis By Indication (Gastric Cancer/Gastroesophageal Junction Cancer, Gastrointestinal Stromal Tumors), By Therapy, By Drug Class, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Gastric Cancer Market (2024 Edition)” which provides a Gastric Cancer/Gastroesophageal Junction Cancer analysis of the Global Gastric Cancer industry in terms of market segmentation By Indication (Gastric Cancer/Gastroesophageal Junction ... Read More
Research Assistance
